MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Clinical trials for MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P) trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cell injection trial hopes to slow rare Parkinson's-Like disease
Disease control Recruiting nowThis early-stage trial tests a single injection of special nerve cells directly into the brain for people with Multiple System Atrophy (MSA), a rare and severe movement disorder. The main goal is to check safety in 9 adults aged 30-70 whose current treatments are not working well…
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Phase: PHASE1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New drug aleeto tested for rare brain disease – early safety check
Symptom relief Recruiting nowThis early-phase study tests whether a new drug called Aleeto is safe and tolerable for people with Multiple System Atrophy (MSA), a rare and serious brain disorder. About 20 participants with the Parkinsonian subtype of MSA will receive Aleeto and be monitored for side effects a…
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Phase: EARLY_PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 16, 2026 12:49 UTC
-
Spinal zap trial aims to stop Parkinson's fainting spells
Symptom relief Recruiting nowThis early study tests whether a spinal cord stimulation device (ARC-IM Therapy) can safely help control blood pressure in people with Parkinson's disease or similar conditions who experience severe dizziness or fainting when standing up. Only 5 participants will be enrolled to c…
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Phase: NA • Sponsor: Ecole Polytechnique Fédérale de Lausanne • Aim: Symptom relief
Last updated Jun 09, 2026 12:06 UTC
-
DNA hunt for brain disease clues: 1,000 volunteers needed
Knowledge-focused Recruiting nowThis study aims to find genes linked to rare brain diseases like PSP, CBS, and MSA. Researchers will collect blood samples from up to 1,000 adults with these conditions and their family members. The goal is to better understand what causes these diseases, not to test a treatment.…
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 17, 2026 03:13 UTC